39 funds hold it.Insiders net selling.
Net selling: insiders sold $20.1M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 20, 2026
Financial period
Q3 2026
Earnings per share
$2.64 expected
Revenue
$2.91B expected
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 20, 2026 | $3.00est. $2.64 | +13.61%beat | $3.05Best. $2.91B+4.88% | +21.7%from $2.51B |
| Jun 30, 2026Reported Jul 16, 2026 | $2.80est. $2.50 | +11.86%beat | $2.89BCompany release | +18.5%from $2.44B |
| Mar 31, 2026Reported Apr 21, 2026 | $2.50est. $2.11 | +18.67%beat | $2.77BSEC filing | +23.0%from $2.25B |
| Dec 31, 2025Reported Jan 22, 2026 | $2.53est. $2.27 | +11.57%beat | $2.87BAlpha Vantage | +18.8%from $2.41B |
| Sep 30, 2025Reported Oct 21, 2025 | $2.40est. $1.99 | +20.60%beat | $2.51BSEC filing | +22.9%from $2.04B |
| Jun 30, 2025Reported Jul 22, 2025 | $2.19est. $1.92 | +14.06%beat | $2.44BSEC filing | +21.4%from $2.01B |
| Mar 31, 2025Reported Apr 22, 2025 | $1.81est. $1.73 | +4.62%beat | $2.25BSEC filing | +19.2%from $1.89B |
| Dec 31, 2024Reported Jan 23, 2025 | $2.21est. $1.79 | +23.46%beat | $2.41BAlpha Vantage | +25.2%from $1.93B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.87B | $2.77B | $2.89B | $3.05B |
| Cost of what it sold | $961.9M | $940.3M | $931.9M | $964.4M |
| Gross profit | $1.90B | $1.83B | $1.96B | $2.08B |
| What it spent | ||||
| Research and development | $352.9M | $361.9M | $370.6M | $408.3M |
| Sales and admin | $687.1M | $613.3M | $617.9M | $1.08B |
| Total operating expenses | $1.04B | $975.2M | $988.5M | $1.49B |
| What was left | ||||
| Operating profit | $864.3M | $855.3M | $971.9M | $592.6M |
| Profit before tax | $955.6M | $940.4M | $1.05B | $668.4M |
| Tax | $156.1M | $114.4M | $231.4M | $144.0M |
| Net profit | $794.8M | $821.5M | $818.1M | $522.8M |
| EBITDA | $1.18B | $1.14B | $1.21B | $668.4M |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
ISRG Gains 7.8% in 6 Months: Will the Share Price Recovery Continue?
Leans bullishNov 9Stryker stock faces lower 2026 outlook after Q3 earnings miss
NeutralNov 9TECH Q1 Earnings & Revenues Beat, Merck KGaA Merger Deal Advances
BullishNov 9NTRA Q3 Loss Wider Than Expected, Revenues Beat, '26 Sales View Up
BullishNov 9Intuitive Surgical, Inc. (ISRG) Seasonal Returns Chart - Yahoo Finance
NeutralNov 7Is Intuitive Surgical’s Next Big Thing Already Here?
Leans bullishNov 7GraniteShares 2x Long ISRG Daily ETF (ISUL) Seasonal returns chart
BullishNov 7Mettler-Toledo Stock Up on Q3 Earnings & Revenue Beat, '26 View Up
BullishNov 6